MedTech News
.................... by Andrew Celentano
New smartphone test to ‘revolutionise’ type 2 diabetes prevention
PocDoc, a leading UK digital health diagnostics company, has launched what it says is the world’s first smartphone-based test for type 2 diabetes risk including the gold-standard blood biomarker, HbA1c, a landmark step in diabetes prevention according to the company.
Ciliatech wins CE mark for implant that treats glaucoma
Ciliatech announced today that it received CE mark approval for its Intercil uveal spacer, an eye implant for treating glaucoma.
HeartFocus launches first clinical product in the U.S. on Butterfly Network handheld ultrasound
HeartFocus announced today that it began the U.S. commercial launch for its AI-enabled cardiac imaging software on Butterfly Network devices.
Philips launches next-gen AI-powered cardiovascular ultrasound offering
Philips (NYSE: PHG)+ announced today that it launched Transcend Plus, the next generation of its cardiovascular ultrasound offerings.
Airiver Medical wins FDA IDE for pulmonary drug-coated balloon
Airiver Medical announced today that it received FDA investigational device exemption (IDE) for its pulmonary drug-coated balloon (DCB).
AI tool helps pinpoint problem heart cells in ventricular tachycardia
An AI tool could help cardiologists identify and target cells that trigger arrhythmia in patients with ventricular tachycardia, a serious heart condition.
Biodegradable self-healing hydrogel combined with acupuncture shows promise for Parkinson’s disease
Researchers at National Taiwan University developed a biodegradable, electroconductive self-healing hydrogel combined with acupuncture that restores motor function and protects brain neurons in Parkinson’s disease models.
AI reveals how protein modifications link mutations to disease
Researchers at Baylor College of Medicine have developed an artificial intelligence (AI) model that reveals how protein modifications link genetic mutations to disease. The method, called DeepMVP and published in Nature Methods, significantly outperforms previously published models and has implications for the development of novel therapeutics.